We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Celgene, Novartis Settle With Barr in Ritalin Patent Dispute
Celgene, Novartis Settle With Barr in Ritalin Patent Dispute
May 11, 2010
Celgene and Novartis Pharmaceuticals have reached a settlement with Barr Laboratories in a patent-infringement lawsuit over the attention-deficit drug Ritalin.